Immuneel Therapeutics Secures ₹100 Crore in Series B Funding Round
Cancer-focused biotech Immuneel Therapeutics raised over Rs 100 crore in Series B funding for expansion.
Read moreDetailsCancer-focused biotech Immuneel Therapeutics raised over Rs 100 crore in Series B funding for expansion.
Read moreDetailsResearch-backed Indian startup journalism. Funding rounds, mergers and acquisitions, AI, and technology — every figure checked against primary sources.
© 2026 StartupSuperb. Research-backed Indian startup news: funding, AI, and technology.
© 2026 StartupSuperb. Research-backed Indian startup news: funding, AI, and technology.